Achalasia: Symptoms, Diagnosis, Treatment & Red Flags
Causes, symptoms, diagnosis, treatment, nursing care, and escalation.
Featured snippet
Achalasia is a condition where the esophagus cannot move food into the stomach properly because the lower esophageal sphincter fails to relax. That physiology drives progressive difficulty swallowing both solids and liquids; teams frequently confuse it with aggressive reflux until timed barium swallow or manometry clarifies the picture.
In clinical depth, achalasia is a primary esophageal motility disorder combining absent effective peristalsis with incomplete relaxation of the lower esophageal sphincter—functionally obstructing esophagogastric emptying. Progressive dysphagia for solids and liquids plus bland regurgitation differentiates it from many reflux-predominant phenotypes; high-resolution manometry (Chicago Classification) confirms diagnosis and assigns prognostically relevant subtypes guiding POEM versus pneumatic dilation choices.
- Triage clue: dysphagia equally affecting solids and liquids with retained saliva or undigested food regurgitation—especially when proton-pump inhibition targeting suspected gastroesophageal reflux disease fails—requires esophageal physiology referral rather than endless dose escalation.
- Gold-standard diagnosis: high-resolution manometry defines absent peristalsis plus abnormal integrated relaxation pressure; adjunct barium esophagram shows bird-beak narrowing when clinically equivocal.
- Therapy ladder: guideline-directed definitive options include graded pneumatic dilation, laparoscopic Heller myotomy (often with partial fundoplication), or POEM—subtype III responds preferentially to extended myotomy approaches.
- Nursing-critical complications: aspiration pneumonia from nocturnal regurgitation and esophageal perforation post-dilation mandate scripted escalation pathways.
- Surveillance nuance: chronic stasis raises esophageal carcinoma vigilance—coordinate oncology timelines when pseudoachalasia features emerge.
⚡ Quick Facts
💡 Clinical Pearl
Heartburn without volumetric relief argues against isolated GERD. Retained esophageal contents ferment microbially—burn may coexist yet dominant history centers on positional regurgitation and meal interruption (nausea symptom framing often accompanies).
📋 Contents
What is Achalasia?
Achalasia denotes degeneration of inhibitory ganglion neurons within the esophageal myenteric plexus—chiefly affecting nitric oxide–mediated pathways governing lower esophageal sphincter (LES) relaxation. Excitatory cholinergic tone persists relatively unchecked, yielding tonic sphincter resistance plus simultaneous failure of propagated peristalsis throughout the esophageal smooth muscle segment.
Without coordinated clearance, swallowed boluses stagnate proximally; adaptive esophageal dilation evolves variably from mild fusiform widening through massively tortuous megaesophagus. Disease biology remains incompletely mapped—autoimmune and viral hypotheses coexist—yet bedside reasoning hinges on obstructive physiology confirmed objectively rather than symptom labels alone.
Eckardt symptom severity score
Eckardt scoring weights dysphagia, regurgitation, retrosternal pain, and weight loss on 0–3 scales—widely employed to quantify baseline burden and treatment response.
| Points each domain | Interpretation | Practice implication |
|---|---|---|
| 0 | Absent | Baseline documentation anchor. |
| 1 | Occasional / mild | Lifestyle tweaks plus referral coordination. |
| 2 | Daily / moderate | Accelerate physiology testing completion. |
| 3 | Severe / constant | Nutrition risk—often aligns with definitive scheduling urgency. |
On a small screen, swipe or scroll sideways to see the full table.
Aggregate totals ≥6 historically correlate with advanced megaesophagus—pair numeric scores with imaging/manometry phenotype rather than treating numbers alone.
When to suspect achalasia
Think achalasia when symptom clusters suggest mechanical esophagogastric hold-up rather than acid-mediated mucosal disease alone.
- Dysphagia pattern: Trouble swallowing solids and liquids from early in the course—not only progressed solids-first obstruction.
- Regurgitation quality: Bland undigested food or pooled saliva, worse lying flat or overnight, distinct from isolated acidic heartburn predominant reflux.
- Poor PPI story: Escalating proton-pump inhibition fails to relieve mechanical fullness or volumetric regurgitation despite reflux-label charts.
- Nutrition flags: Unintentional weight loss, prolonged meals, manoeuvres (arching neck, liquids to “wash down”) without identifiable mucosal stricture.
- Pulmonary overlap: Recurrent aspiration-type pneumonia or chronic cough temporally tied to recumbent regurgitation.
- Rapid alarm subset: Short symptom latency with profound cachexia raises pseudoachalasia—prioritize timely endoscopy and oncology-directed workup rather than assuming benign motility disease.
Validated suspicion prompts esophageal physiology referral (typically high-resolution manometry ± adjunct esophagram); documenting these cues speeds diagnosis after months or years of symptom misattribution.
Symptoms
Course is insidious; intervals between onset and diagnosis commonly span years unless teams recognise early simultaneous solid-and-liquid difficulty swallowing.
Typical patterns
- Mechanical dysphagia escalating without discriminatory solids-only phase.
- Bland regurgitation hours post-prandially—distinct from acidic post-reflux vomitus.
- Nocturnal coughing or aspiration-linked pneumonia precipitates.
Atypical masqueraders
- Substernal chest pain mimicking cardiac ischemia—maintain coordinated cardiology exclusion before anchoring purely esophageal labels.
- Heartburn interpreted as uncomplicated GERD despite abnormal swallow mechanics.
Causes and Risk Factors
Primary idiopathic achalasia dominates referral cohorts; secondary phenotypes mimic physiology after infiltrative malignancy (pseudoachalasia), Chagas-mediated neuronal destruction, or rare autoimmune overlap syndromes.
Non-modifiable
- Genetic predisposition—familial clustering documented albeit uncommon.
- Age-related degenerative neuron attrition hypotheses.
Modifiable triggers (supportive care orientation)
- Nutrition density optimisation pending definitive therapy rather than enduring prolonged fasting.
- Avoid repeated blind PPI escalation without physiology confirmation—delays invasive salvage timelines.
How is it Diagnosed?
Clinical assessment
History targeting simultaneous dysphagia substrates plus bronchoscopic pneumonia cycles guides urgency; examine for wasting and pulmonary basal crackles suggesting aspiration sequelae (abdominal assessment complements evaluating gastric epigastric tenderness mimics).
Laboratory investigations
Routine labs lack specificity—use albumin and micronutrient indices when malnutrition suspected.
Imaging
Timed barium esophagram complements manometry—classic bird-beak taper plus impaired esophageal emptying reinforce suspicion during catheter scheduling delays.
Physiology criteria
High-resolution manometry remains definitive—integrated relaxation pressure elevation plus 100% absent peristalsis satisfies Chicago Classification achalasia definitions with subtype stratification (I classic absent pressurisation; II pan-oesophageal pressurisation; III distal spastic contractions).
Endoscopy
Routine esophagogastroduodenoscopy excludes mucosal mimics—document retained saliva lakes and retroflexed cardia morphology.
Differential Diagnoses
| Alternative | Distinguishing clues |
|---|---|
| GERD / reflux hypersensitivity | Predominant acidic regurgitation responsive temporarily to PPI trials; manometry preserves peristalsis. |
| Peptic stricture | Usually solids-first dysphagia—endoscopic lesion overt. |
| Eosinophilic esophagitis | Endoscopic rings/exudates—biopsy eosinophilia diagnostic. |
| Systemic sclerosis esophagus | Hypotensive LES with GERD prominence—manometric contrast instructive. |
| Pseudoachalasia | Rapid symptom tempo with disproportionate weight loss—oncologic workup urgent. |
On a small screen, swipe or scroll sideways to see the full table.
Treatment Options
No modality restores peristalsis—care lowers LES outflow resistance while balancing GERD sequelae.
First-line definitive therapies
- Pneumatic dilation: graded balloon disruption—effective across Chicago types I–II with perforation counselling.
- Laparoscopic Heller myotomy ± Dor/Toupet fundoplication: durable mechanical disruption paired with reflux mitigation surgery.
- POEM: submucosal tunnel myotomy—particularly leveraged for subtype III yet associates with higher objective reflux burden mandating disciplined PPI pathways (omeprazole exemplifies guideline PPI pharmacotherapy).
Bridging / salvage adjuncts
- Botulinum toxin LES injection—temporary bridge for poor surgical candidates.
- Smooth-muscle relaxants (nitrates, calcium-channel antagonists)—limited sustained efficacy.
- Esophagectomy reserved for end-stage megaesophagus refractory to lesser modalities.
Special populations
- Geriatrics: Frail patients may prioritise toxin or gentle dilation—still observe aspiration nets.
- Pregnancy: Coordinate fetal-safe anesthesia exposure—defer elective pneumatic dilation timing when unstable nutrition absent.
Clinical Practice Considerations
- Monitoring cadence: Repeat Eckardt scoring 4–8 weeks post definitive therapy—or sooner if obstructive relapse suspected.
- Treatment failure: Persistent dysphagia scores despite optimisation warrants repeat manometry imaging dialogue—not empirical dilation repetition without physiology.
- Drug interactions: Long-term PPI therapy post-myotomy merits renal/hepatic dosing adjustments when polypharmacy escalates.
- Referral thresholds: Suspected perforation, aspiration pneumonia, or nutritional BMI collapse mandate same-day gastroenterology/surgery coordination.
- Documentation: Record aspiration precautions signed alongside dietary texture orders (feeding tube care workflow when enteral supplementation initiated).
Antiemetic peri-support
Procedure-linked nausea responds to serotonin antagonists—align timing with anesthesia protocols (ondansetron monograph).
Escalation triggers checklist
- Fever + mediastinal chest pain hours post pneumatic dilation.
- Hypoxia with recurrent low-grade infiltrates unexplained otherwise.
Possible Complications
- Aspiration pneumonia / bronchiectasis from chronic regurgitation.
- Esophagitis—acid or candidal—in poorly emptied esophagus.
- Elevated esophageal squamous carcinoma risk albeit absolute incidence modest—maintain pragmatic surveillance literacy.
- Severe malnutrition cascade.
Prevention
Achalasia itself is not preventable—clinical prevention centres on shortening diagnostic latency (avoid anchoring on GERD alone), enforcing aspiration precautions once suspicion crystallises, and maintaining reflux surveillance after sphincter-disruptive therapies.
Prognosis and Outlook
Type II generally achieves highest durable symptom relief with pneumatic dilation or myotomy; type III carries tougher contraction physiology demanding extended myotomy approaches. Patients remain chronically esophageal dysmotile—counsel lifelong gastroenterology partnerships despite symptom-free intervals.
In Clinical Practice…
Dysphagia safety
Upright feeding posture, pocket suction readiness during bedside trials, supervised oral hygiene post-regurgitation episodes.
Education anchors
Explain distinction between GERD-centric dietary triggers versus mechanics of esophageal retention—prevents inappropriate acidic-food avoidance alone.
Communication barriers
Pain descriptors overlapping cardiac vocabulary benefit structured translators ensuring dual cardiology/GI escalation clarity.
When to Seek Emergency Care
- Suspected esophageal perforation post-intervention—severe thoracic pain, subcutaneous emphysema, sepsis pattern.
- Airway compromise from massive aspiration.
- Hemodynamic instability with suspected mediastinitis.
NCLEX practice questions
These NCLEX-style clinical judgment practice items focus on the nursing priorities in achalasia: dysphagia and aspiration risk, keeping the patient upright and nil by mouth when regurgitation occurs, escalating suspected aspiration pneumonia or post-procedure perforation, and watching for red flags after myotomy (recurrent dysphagia, haematemesis, weight loss). Specialist details such as manometry subtypes, pseudoachalasia and the Heller / POEM / pneumatic-dilation ladder appear as context for the clinical-judgment reasoning, not as primary memorisation targets.
Unfolding case (Questions 1–3): Mrs. P., 52, presents with 14 months of progressive dysphagia for both solids and liquids, regurgitation of undigested food (especially at night), nocturnal cough and 6 kg unintentional weight loss. Barium swallow shows a dilated oesophagus with a “bird-beak” distal narrowing; high-resolution manometry confirms an elevated integrated relaxation pressure with no peristalsis (type II achalasia). Upper endoscopy excludes mass at the gastroesophageal junction.
Answer key & rationale
Which symptom pattern most reliably distinguishes achalasia from uncomplicated GERD?
Progressive dysphagia to both solids and liquids with retained bolus sensation and bland regurgitation of undigested food—especially when acid-suppressive trials targeting GERD fail—should trigger targeted esophageal testing rather than indefinite PPI escalation.
How quickly should suspected esophageal perforation after pneumatic dilation be escalated?
Treat sudden thoracic pain, subcutaneous emphysema, fever, or hemodynamic instability after dilation as time-critical—immediate surgical / acute gastroenterology activation per institutional perforated-viscus pathways.
Why do teams pair post-myotomy protocols with reflux precautions?
LES disruption improves emptying but predisposes to GERD and esophagitis—many pathways combine partial fundoplication or structured PPI plans with symptom surveillance.
What bedside cues raise suspicion for pseudoachalasia?
Short-interval symptom onset in older adults, pronounced weight loss disproportionate to intake duration, or endoscopic masses at the gastro-esophageal junction mandate oncology-directed staging—not empiric dilation alone.
When is aspiration precaution teaching mandatory?
Nocturnal regurgitation, chronic pulmonary infiltrates, or witnessed coughing during meals warrants upright positioning after meals, dietary texture counselling, and frequent oral suction readiness pending definitive therapy.
How often are Eckardt scores trended around invasive therapy?
Specialty clinics commonly reassess Eckardt severity weeks after pneumatic dilation or myotomy—document baseline pre-procedure scores so nursing handoffs quantify symptomatic shift objectively.
Can calcium-channel blockers replace definitive therapy?
Medical bridging occasionally reduces sphincter tone transiently but lacks durability—use only while arranging guideline-directed definitive modalities unless contraindications prohibit intervention.
Does botulinum toxin obviate repeat procedures?
LES injections produce temporary relaxation lasting months—expect recurrent symptoms and maintain proactive referral unless lifelong palliation alone aligns with patient goals.
- Momodu II, Wallen JM. Achalasia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.https://www.ncbi.nlm.nih.gov/books/NBK519515/
- NHS. Achalasia.https://www.nhs.uk/conditions/achalasia/
- Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG Clinical Guidelines: Diagnosis and Management of Achalasia. Am J Gastroenterol. 2020.https://pubmed.ncbi.nlm.nih.gov/32773454/
- Khashab MA, Vela MF, Thosani N, et al. ASGE guideline on the management of achalasia. Gastrointest Endosc. 2020.https://pubmed.ncbi.nlm.nih.gov/31839408/
- Gyawali CP, Carlson DA, Chen JW, et al. ACG clinical guideline: Clinical use of esophageal physiologic testing. Am J Gastroenterol. 2020.https://pubmed.ncbi.nlm.nih.gov/32769426/
- Lynch KL. Achalasia. Merck Manual Professional Edition (reviewed Feb 2026).https://www.merckmanuals.com/professional/gastrointestinal-disorders/esophageal-and-swallowing-disorders/achalasia
- Mittal RK, Vaezi MF. Esophageal Motility Disorders and Gastroesophageal Reflux Disease. N Engl J Med. 2020.https://pubmed.ncbi.nlm.nih.gov/33176086/
- Savarino E, Bhatia S, Roman S, et al. Achalasia. Nat Rev Dis Primers. 2022.https://pubmed.ncbi.nlm.nih.gov/35513420/
- Azer SA, Kanugula AK, Kshirsagar RK. Dysphagia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026.https://www.ncbi.nlm.nih.gov/books/NBK559174/
- American College of Gastroenterology. Achalasia (patient topic overview).https://gi.org/topics/achalasia/
